ChristianaCare Gene Editing Institute

The Gene Editing Institute explores the potential of CRISPR-directed gene editing for application in oncology and inherited disease. We focus on bringing innovative research from bench to bedside by using CRISPR-directed gene editing to mitigate the failure of standard cancer care. Our education and outreach program aims to demystify gene editing technology while enriching STEM education at both the high school and collegiate level with CRISPR in a Box?. Want to learn more? Visit our website or send us a message on LinkedIn. We're eager to collaborate in research and education to further CRISPR's integration into our community and our healthcare.

Happy Thanksgiving to you and yours from the Gene Editing Institute! Our commitment to gene editing advancements and translational discoveries is based in our patient-centric mission. We seek to serve our community in every step of our research. Today, we're thankful for all of our scientists, educators, and admin staff that advance the goals of the Gene Editing Institute. Thank you for joining us on this journey!

We hosted Cecil County School of Technology this week in Learning Lab! Students had the chance to perform the CRISPR in a Box experiment, talk to an expert in the field from our lab, and practice their laboratory skills with dedicated teachers. These students are about to start the lab component of their capstone project and asked London McGill for some tips. "If you get a result you weren't expecting, and then you repeat the experiment and get the same result, that's not a failure," she said. "It's a door to re-thinking your question and finding out something different. Science isn't always about getting the 'right' answer. There's no right answer in science. What science is about is discovery and continuing to seek results, no matter what comes your way." There's still Learning Labs available in December and the upcoming spring! If you want to lead your students on their own journey of discovery, visit our website and book today.

We're excited to see Kelly Banas present for CRISPR Medicine News's webinar next week! She'll be discussing her team's development of a unique strategy to disrupt NRF2, a key gene involved in drug resistance in solid tumors, to augment standard of care therapies. This is research that she's grown intimately familiar with over the past nine years, and we're proud to see her go in front of an international stage to present it to the public. Find the link to the webinar in our comments and sign up today to reserve your spot.

What a week! Let's recap: 1. We co-hosted BioBreakfast at the Ammon Education Center, speaking to oncologists, professionals, and leaders in the area about our current trajectory in gene editing research. Joined by fellow speaker Omar Khan, Eric B. Kmiec gave a presentation that prompted discussions on the advances of healthcare research and analytical tools for genomic researchers. 2. We attended Advanced Therapies 2024, setting up a booth with our educational and technological content and connecting with an international audience! We were so thrilled to bring the Gene Editing Institute to the Philadelphia Convention Center. Between sessions, keynotes, and individual connections at our booth, we saw hundreds of people and engaged with them on our mission, our values, and our plans for the future! 3. We sent Sarah LaTorre, our education program coordinator, to California to attend NABT's 2024 conference in Anaheim! She saw the sights, shared information about CRISPR in a Box with the nation's biology teachers and hosted some workshops to fully show off the kit's capabilities. She also got to enjoy some sunnier weather than us as November chill sets in on the east coast; lucky her! We're extremely proud to continue sharing our story to a wider audience, and opportunities like this mean we get to make solid connections in the community and learn about the range of therapeutics being developed by institutes and companies around the world. Genomic medicine is still only at the beginning of its capabilities. Every day, we see more evidence that assures us that this is the future of treatment, from rare diseases to cancers to widespread inherited illnesses. Our hope is to continue that trend with a patient-first approach, so we always know we're sticking up for our community. Catch us next week at the 9th International Conference on Cancer Research & Drug Development in Boston, MA! We're not slowing down yet!

Day 1 of Advanced Therapies is in full swing! We're meeting experts in the field who are eager to connect about new developments, novel biotechnologies, and opportunities to engage with the next generation. If you're here, find us at Booth 510!

It's tomorrow! Join us at Advanced Therapies! Get your ticket now for an unmissable convention of leaders in the life science, genetic medicine, and genomic technology fields as they join together to advance the common cause of innovating and furthering the wonder of gene editing for all. Eric B. Kmiec will present a talk on the Institute's current research, and we'll run a booth for attendees to come by and learn about our DECODR and Learning Lab programs. You'll find the link to this conference in the comments of this post. We hope to see you there!

We're excited to join Delaware BioScience Association for their BioBreakfast this November! Speakers from our institute will present and network, giving us the chance to engage with the Delaware science community while also supporting one of our favorite partner organizations! Make sure you get your tickets soon! Link is down in the comments.

Reflecting back on the wonderful trip I had to visit OU Health Stephenson Cancer Center and share the exciting work happening at ChristianaCare Gene Editing Institute and CorriXR Therapeutics Thanks Deborah Moorad and James Battiste for hosting and showing us around OKC!

Nothing's scary about CRISPR, but there's something spooky about our scientists today! We're enjoying the holiday by dressing up. To all the trick-or-treaters and celebrators of the day: go 'bananas' tonight, but don't go too crazy on the candy - maybe just a 'bite'!